181 related articles for article (PubMed ID: 24294178)
21. Rab27b is associated with fusiform vesicles and may be involved in targeting uroplakins to urothelial apical membranes.
Chen Y; Guo X; Deng FM; Liang FX; Sun W; Ren M; Izumi T; Sabatini DD; Sun TT; Kreibich G
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14012-7. PubMed ID: 14625374
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
[TBL] [Abstract][Full Text] [Related]
23. Involvement of vps33a in the fusion of uroplakin-degrading multivesicular bodies with lysosomes.
Guo X; Tu L; Gumper I; Plesken H; Novak EK; Chintala S; Swank RT; Pastores G; Torres P; Izumi T; Sun TT; Sabatini DD; Kreibich G
Traffic; 2009 Sep; 10(9):1350-61. PubMed ID: 19566896
[TBL] [Abstract][Full Text] [Related]
24. Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli.
Thumbikat P; Berry RE; Schaeffer AJ; Klumpp DJ
Microbes Infect; 2009 Jan; 11(1):57-65. PubMed ID: 19007907
[TBL] [Abstract][Full Text] [Related]
25. Uroplakins play conserved roles in egg fertilization and acquired additional urothelial functions during mammalian divergence.
Liao Y; Chang HC; Liang FX; Chung PJ; Wei Y; Nguyen TP; Zhou G; Talebian S; Krey LC; Deng FM; Wong TW; Chicote JU; Grifo JA; Keefe DL; Shapiro E; Lepor H; Wu XR; DeSalle R; Garcia-España A; Kim SY; Sun TT
Mol Biol Cell; 2018 Dec; 29(26):3128-3143. PubMed ID: 30303751
[TBL] [Abstract][Full Text] [Related]
26. Postnatal restoration of the mouse urinary bladder urothelium.
Erman A; Jezernik K; Stiblar-Martincic D; Romih R; Veranic P
Histochem Cell Biol; 2001 Apr; 115(4):309-16. PubMed ID: 11405059
[TBL] [Abstract][Full Text] [Related]
27. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial lipid droplet formation as a detoxification mechanism to sequester and degrade excessive urothelial membranes.
Liao Y; Tham DKL; Liang FX; Chang J; Wei Y; Sudhir PR; Sall J; Ren SJ; Chicote JU; Arnold LL; Hu CA; Romih R; Andrade LR; Rindler MJ; Cohen SM; DeSalle R; Garcia-España A; Ding M; Wu XR; Sun TT
Mol Biol Cell; 2019 Nov; 30(24):2969-2984. PubMed ID: 31577526
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.
Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF
Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780
[TBL] [Abstract][Full Text] [Related]
30. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Zupančič D; Ovčak Z; Vidmar G; Romih R
Virchows Arch; 2011 May; 458(5):603-13. PubMed ID: 21301865
[TBL] [Abstract][Full Text] [Related]
31. Formation of asymmetric unit membrane during urothelial differentiation.
Sun TT; Zhao H; Provet J; Aebi U; Wu XR
Mol Biol Rep; 1996; 23(1):3-11. PubMed ID: 8983014
[TBL] [Abstract][Full Text] [Related]
32. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases.
Kong XT; Deng FM; Hu P; Liang FX; Zhou G; Auerbach AB; Genieser N; Nelson PK; Robbins ES; Shapiro E; Kachar B; Sun TT
J Cell Biol; 2004 Dec; 167(6):1195-204. PubMed ID: 15611339
[TBL] [Abstract][Full Text] [Related]
33. Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly.
Deng FM; Liang FX; Tu L; Resing KA; Hu P; Supino M; Hu CC; Zhou G; Ding M; Kreibich G; Sun TT
J Cell Biol; 2002 Nov; 159(4):685-94. PubMed ID: 12446744
[TBL] [Abstract][Full Text] [Related]
34. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease.
Stahlschmidt J; Varley CL; Toogood G; Selby PJ; Southgate J
Kidney Int; 2005 Sep; 68(3):1032-40. PubMed ID: 16105033
[TBL] [Abstract][Full Text] [Related]
35. Molecular ultrastructure of the urothelial surface: insights from a combination of various microscopic techniques.
Zupančič D; Romih R; Robenek H; Žužek Rožman K; Samardžija Z; Kostanjšek R; Kreft ME
Microsc Res Tech; 2014 Nov; 77(11):896-901. PubMed ID: 25060677
[TBL] [Abstract][Full Text] [Related]
36. Endocytotic activity of bladder superficial urothelial cells is inversely related to their differentiation stage.
Kreft ME; Romih R; Kreft M; Jezernik K
Differentiation; 2009 Jan; 77(1):48-59. PubMed ID: 19281764
[TBL] [Abstract][Full Text] [Related]
37. Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation.
Kreft ME; Sterle M; Veranic P; Jezernik K
Histochem Cell Biol; 2005 Jun; 123(4-5):529-39. PubMed ID: 15868181
[TBL] [Abstract][Full Text] [Related]
38. Cyclic hydrostatic pressure promotes uroplakin expression in human urothelial cells through activation of ERK1/2 signaling.
Gao X; Wei T; Chen J; Ai J; Jin T; Cheng L; Liu Y; Xiao K; Zeng X; Wang K
Biochem Biophys Res Commun; 2018 Sep; 503(4):2499-2503. PubMed ID: 30208517
[TBL] [Abstract][Full Text] [Related]
39. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
40. Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.
Huang HY; Shariat SF; Sun TT; Lepor H; Shapiro E; Hsieh JT; Ashfaq R; Lotan Y; Wu XR
Hum Pathol; 2007 Nov; 38(11):1703-13. PubMed ID: 17707461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
